 |
 |
|
|
|
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
||||
 |
 |
 |
 |
 |
 |
||||
 | |||||
|
AMCP - December 2012 |
 |
EUNetHTA - August 2012 |
|
EUNetHTA - August 2012 |
|
EUNetHTA - June 2012 |
|
EUNetHTA - August 2012 |
|
EUNetHTA - June, 2nd, 2012 |
|
Belgian Presidency of the European Union - 23-24 September 2010 |
|
High Level Pharmaceutical forum - June 26, 2007 |
|
Centre for Health Economics, University of York. Mark Sculpher, Karl Claxton, Mike Drummond - January 2005 |
|
EFPIA - European Federation of Phramaceutical Industries and Associations - July 2005 |
|
CRD - Center for Reviews and Dissemination, University of York - January 2009 |
|
FMCP - AMCP - January 2010 |
|
Moher D. , Liberati A. , Teztlaff J. et al, Ann Intern Med. 2009 ;151. - July 2009 |
|
Department of Health, UK - July 2010 |
|
ISPOR-SMDM Task Force - June 2011 |
|
The Pharmaceutical Forum - October 2008 |
|
European Medicines Agency - January 2010 |
|
European Network for Health Technology Assessment (EUnetHTA) - July 2011 |
|
ISPOR-SMDM Task Force - June 2011 |
|
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, - January 2011 |
|
U.S. Department of Health and Human Services Food and Drug Administration - May 2011 |
|
Department of Health, UK - 16 décembre 2010 |
|
Danish Centre for Health Technology Assessment, National Board of Health - February 15th, 2008 |
|
CDRH - Center for Devices and Radiological Health, Dr. Greg Campbell - February 5th, 2010 |
|
IQWIG - November 11th, 2009 |
|
Centre for Review and Dissemination - NHS Economic Evaluation Database (NHS EED) - December 2009 |
|
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH) - December 2009 |
|
Evelina Zimovetz, Sorrel Wolowacz - ISPOR 12th Annual European Congress, October 2009, Paris |
|
Report brief, Institute of Medicine - June 2009 |
|
Federal Coordinating Council for Comparative Effectiveness Research - June 30, 2009 |
|
NHS - National Institute for Health and Clinical Excellence - June 2008 |
|
European Network for Health Technology Assessment (EUnetHTA) - July 11, 2007 |
|
IQWIG - October 9, 2008 |
|
House of Commons Health Committee - December 17, 2007 |
|
Draft for consultation, NICE Guidelines - January 2008 |
|
Institute of Medicine (USA) - Roundtable on evidence-based medicine - 2008 |
|
National Institute for Health and Clinical Excellence. - November 26, 2007 |
|
National Institute for Health and Clinical Excellence. - November 2007 |
|
Office of Fair Trading - November 2007. |
|
ISPOR - September 2007 |
|
The Cochrane Collaboration - May 2005 |
|
European Medicines Agency, June 2010 |
|
Center for Medical Technology Policy, September 2010 - Effectiveness guidance document |
|
May-June 2009 - Falissard B, Zylberman M, Cucherat M, Izard V, Meyer F, Thérapie 2009 Mai-Juin ; 64 (3) : 225-228 |
|
- Teresa L Kauf, PhD |
|
- Franco Sassi, LSE. |
|
- Mark V. Pauly, Henry Glick, Wharton. |
|
- John A. Nyman, Ph.D |
|
- Mark Roberts, MD MPP |
|
 |
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
